Clinical significance of serologic markers related to red blood cell autoantibodies production after red blood cell transfusion - Severe autoimmune hemolytic anemia occurring after transfusion and alloimmunization: Successful treatment with rituximab

Transfusion

Volumn 49, Issue 7, 2009, Pages 1370-1374

  Sigler, Erica ^a   Shvidel, Lev ^b   Yahalom, Vered ^b   Berrebi, Alain ^b   Shtalrid, Mordechai ^b  

^a KAPLAN MEDICAL CENTER   (Israel)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; AUTOANTIBODY; ERYTHROCYTE ANTIBODY; IMMUNOGLOBULIN ANTIBODY; RITUXIMAB; STEROID;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE HEMOLYTIC ANEMIA; BLOOD BANK; BLOOD TRANSFUSION; CASE REPORT; CLINICAL ARTICLE; CLINICAL FEATURE; EPITOPE MAPPING; ERYTHROCYTE TRANSFUSION; FEMALE; HEMOLYTIC ANEMIA; HUMAN; LYMPHOMA; MALE; RETROSPECTIVE STUDY; SERODIAGNOSIS; TREATMENT OUTCOME;

AGED, 80 AND OVER; ANEMIA, HEMOLYTIC, AUTOIMMUNE; ANTIBODIES, MONOCLONAL; AUTOANTIBODIES; ERYTHROCYTE TRANSFUSION; FEMALE; HUMANS; IMMUNOLOGIC FACTORS;

EID: 67649933081     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2009.02163.x     Document Type: Article

References (14)

1. Dameshek W, Levine P. Isoimmunization with Rh factor in acquired hemolytic anemia. N Engl J Med 1943 228 : 641 4.
2. Talano JA, Hillery CA, Gottstschall JL, Baylerian DM, Scott JP. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome with sickle cell disease. Pediatrics 2003 111 : e661 5.
3. Singer ST, Wu V, Mignacca R, Kuypers FA, Morel P, Vichinsky EP. Alloimmunization and erythrocyte autoimmunization in transfusion-dependent thalassemia patients of predominantly Asian descent. Blood 2000 96 : 3369 73.
4. King KE, Shirey RS, Lankiewicz MW, Young-Ramsaran J, Ness PM. Delayed hemolytic transfusion reactions in sickle cell disease: simultaneous destruction of recipients' red cells. Transfusion 1997 37 : 376 81.
5. Ahrens N, Pruss A, Kahne A, Kiessewetter H, Salama A. Coexistence of autoantibodies and alloantibodies to red blood cells due to blood transfusion. Transfusion 2007 47 : 813 6.
6. Aygun B, Padmanabhan S, Paley C, Chandrasekaran V. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Transfusion 2002 42 : 37 43.
7. Young PP, Uzieblo A, Trulock E, Lublin DM, Goodnough LT. Autoantibody formation after alloimmunization: are blood transfusions a risk factor for autoimmune hemolytic anemia? Transfusion 2004 44 : 67 72. (Pubitemid 38177138)
8. Garratty G. Autoantibodies induced by blood transfusion. Transfusion 2004 44 : 5 9. (Pubitemid 38177129)
9. Vendelen-Tyler V. Technical manual. 14th ed. Bethesda (MD) : American Association of Blood Banks 2003.
10. Petz LD, Garratty G. Acquired immune hemolytic anemias. New York, Edinburgh and London : Churchill Livingstone Inc 1980.
11. Garvey B. Rituximab in the treatment of autoimmune haematological disorders. Br J Haematol 2008 141 : 149 69.
12. Dacie SJ. The immune hemolytic anaemia: a century of exciting progress in understanding. Br J Haematol 2001 114 : 770 85.
13. Vanderlugt CJ, Miller SD. Epitope spreading. Curr Opin Immunol 1996 8 : 831 6.
14. Zimring JC, Spitalnik SL, Roback JD, Hillyer CD. Transfusion-induced autoantibodies and differential immunogenity of blood group antigens: a novel hypothesis. Transfusion 2007 47 : 2189 96.